[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 7, 2007

Advanced Prostate Cancer and Postoperative Radiotherapy

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(9):950-951. doi:10.1001/jama.297.9.950-b

To the Editor: The randomized clinical trial by Dr Thompson and colleagues1 of adjuvant postoperative radiotherapy for patients with advanced prostate cancer validated the results of a European study that included more patients but had shorter follow-up.2 Because of lower than expected event rates, it was improbable that the primary endpoint of improved metastasis-free survival would be observed unless radiotherapy was particularly effective at preventing spread of residual prostatic fossa cancer, salvage radiotherapy for a detectable prostate-specific antigen level or hormonal therapy did not prevent metastasis, and death from causes other than prostate cancer did not reduce metastasis-free survival.

First Page Preview View Large
First page PDF preview
First page PDF preview
×